This Public Health England resource contains data and findings from the hepatitis C patient registry and treatment outcome system. Data from the registry shows that DAA treatments have successfully cured 95% of patients who received them. The vast majority of treatment continues to take place within secondary care, with just 13% of treatments undertaken in drug services, prisons or other outreach settings.
Clinical Review of the Impacts of Hepatitis C: Short Life Working Group Report for the Scottish Government
Visit https://beta.gov.scot/publications/clinical-review-impacts-hepatitis-c-short-life-working-group-report/
This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.
